PDT Partners LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 21.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 55,600 shares of the healthcare conglomerate’s stock after acquiring an additional 9,700 shares during the period. PDT Partners LLC’s holdings in UnitedHealth Group were worth $10,309,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in the business. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group in the second quarter worth about $110,000. Kings Point Capital Management increased its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares in the last quarter. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares in the last quarter. Finally, BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth about $121,000. 86.20% of the stock is currently owned by institutional investors and hedge funds.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.33 during trading hours on Wednesday, reaching $220.09. 3,246,300 shares of the company traded hands, compared to its average volume of 3,119,193. The stock has a market capitalization of $214,570.92, a PE ratio of 23.07, a P/E/G ratio of 1.64 and a beta of 0.66. UnitedHealth Group Incorporated has a 12 month low of $156.09 and a 12 month high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 33.26%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. In the last three months, insiders sold 57,606 shares of company stock valued at $11,566,525. Corporate insiders own 0.89% of the company’s stock.
Several equities analysts have recently weighed in on UNH shares. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Cantor Fitzgerald lifted their target price on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Credit Suisse Group started coverage on shares of UnitedHealth Group in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 target price for the company. UBS reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Finally, Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $224.56.
TRADEMARK VIOLATION WARNING: “PDT Partners LLC Increases Holdings in UnitedHealth Group Incorporated (UNH)” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://stocknewstimes.com/2017/12/06/pdt-partners-llc-increases-holdings-in-unitedhealth-group-incorporated-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.